Imunon Says Jeffrey Church To Retire As Interim CFO Effective July 1, 2026; Appoints Josh Blacher As Interim CFO Effective July 1, 2026
On June 29, 2026, Jeffrey Church informed Imunon, Inc. (the "Company") of his intent to retire from the position of interim Chief Financial Officer (a position he has held since January of 2026), effective July 1, 2026 (the "Retirement Date"). To help ensure a smooth transition of his responsibilities to his successor, Mr. Church and the Company agreed that he will continue in a consulting role with the Company. The Company and Mr. Church amended the Consulting Agreement, effective July 1, 2026, pursuant to which, the Company agreed to pay Mr. Church a monthly retainer of $10,000 (that may be terminated upon 2 business days’ notice). Mr. Church’s departure is due to retirement and is without any disagreements with management.
On June 29, 2026, Jeffrey Church informed Imunon, Inc. (the "Company") of his intent to retire from the position of interim Chief Financial Officer (a position he has held since January of 2026), effective July 1, 2026 (the "Retirement Date").
To help ensure a smooth transition of his responsibilities to his successor, Mr.
Church and the Company agreed that he will continue in a consulting role with the Company.
The Company and Mr.
Church amended the Consulting Agreement, effective July 1, 2026, pursuant to which, the Company agreed to pay Mr.
Church a monthly retainer of $10,000 (that may be terminated upon 2 business days’ notice).
Mr.
Church’s departure is due to retirement and is without any disagreements with management.